Marco Mariani - Publications

Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort.

Journal: Dermatology practical & conceptual

Published: April 15, 2024

Drug survival of biologics and non-biologics in patients affected by palmoplantar psoriasis: a "real-world", mono-center experience.

Journal: International journal of dermatology

Published: September 06, 2023

Association of national smoke-free policies with per-capita cigarette consumption and acute myocardial infarction mortality in Europe.

Journal: Journal of epidemiology and community health

Published: April 19, 2023

Intake of Proton-Pump Inhibitors and Gastric Cancer within the Stomach Cancer Pooling (StoP) Project.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: March 14, 2023

Leisure-time physical activity and gastric cancer risk: A pooled study within the Stomach cancer Pooling (StoP) Project.

Journal: PloS one

Published: January 09, 2023

Drug survival of methotrexate and predictor factors for discontinuation in psoriasis.

Journal: International journal of dermatology

Published: November 24, 2022

Chronic metformin intake and gastric cancer: A pooled analysis within the Stomach cancer Pooling (StoP) Project.

Journal: Cancer epidemiology

Published: March 31, 2022

Impact of hospital mergers: a systematic review focusing on healthcare quality measures.

Journal: European journal of public health

Published: February 14, 2022

Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.

Journal: Dermatologic therapy

Published: December 05, 2021

The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.

Journal: Frontiers in public health

Published: September 30, 2021

Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study.

Journal: Clinical drug investigation

Published: August 31, 2021

Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

Journal: Expert opinion on biological therapy

Published: July 19, 2021